Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Medical cannabis

Davos report highlights UK doctors' fears around medical cannabis prescribing

UK-based specialist doctors may be reluctant to prescribe medical cannabis because there is a lack of “infrastructure to support them should something go wrong”, the World Economic Forum’s annual meeting has heard.

The claim is made in the 4th European Cannabis Report, produced by business analysts Prohibition Partners and launched during a Cannabis Conclave — held in Davos, Switzerland, on 24 January 2019.

The report says that NHS doctors have had little guidance to support them in the prescribing of medical cannabis, and that the guidance that does exist is regarded by some politicians as overly restrictive.

In a press release accompanying the report, Stephen Murphy, co-founder of Prohibition Partners, said: “A lack of educational infrastructure and prohibitive costs are impeding UK patient access to potentially transformative cannabis medicines … these factors have slowed medicinal cannabis use and pushed patients into the black market.”

However, the firm is optimistic about the future of the market for medical cannabis in the UK. Although it suggests that “inaccessibility to legal cannabis will slow growth in the short term”, it predicts that by 2028 the annual market value for medical cannabis in the UK will be around £8.8bn per annum.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206057

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.